Dr. Lingxiao Zhang is currently a Marie Sklodowska-Curie Actions Research Fellow, who has expertise in biomedical engineering, materials sciences, and immunology. Before joining Aarhus University, he was a research assistant professor and then associate professor at Zhejiang University. He has published over 35 peer-reviewed articles in Adv. Mater., Adv. Sci., Coord. Chem. Rev., Adv. Funct. Mater., Acta Pharm. Sin. B, ACS Nano, Adv. Drug Deliv. Rev., Nano Today, etc. 

My iterdisciplinary research focuses on the development and application of next-generation nano-aluminum adjuvants (NanoAlum) for drug delivery and immunotherapy, including:

(1) Next-generation NanoAlum (materials science);

(2) Particle-tissue-cell interaction (biomechanics);

(3) Material-immune cell behavior (immunology);

(4) Tumor-neuron-immune interaction (neuroscience)

Editor: J. Nanobiotech.; Exploration

Editorial board member: Asian J. Pharm. Sci.; Chi. Chem. Lett.; Exploration; VIEW; Microstructures; Biomaterials Transl.; Neural Reg. Res.

Reviewer: Adv. Mater., Coord. Chem. Rev., Acta Pharm. Sinica B, Mol. Cancer, Adv. Sci., Adv. Healthc. Mater., Brain Behav. Immunity, Acta Biomaterialia, Exploration, Nanoscale, Nanoscale Hor., J. Nanobiotech., Mater. Today Phy., Acta Neuropath. Commun., J. Mater. Chem. B, Chi. Chem. Lett., Neural Reg. Res., Mol. Pharm.